Viewing data from:

NIMODIPINE

ANDA

NIMODIPINE | A077811 | HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$1.21

per ea

Lowest NADAC/Unit

$1.21

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
23155051200NIMODIPINE 30 MG CAPSULE	$1.21	EA	Generic	—	2026-06-17
23155051230NIMODIPINE 30 MG CAPSULE	$1.21	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs5 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

LUSOCHIMICA SPANIMODIPINE

DMF 149792000

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)NIMODIPINE (MICRONIZED)

DMF 169512003

DASAMI LAB PRIVATE LTDNIMODIPINE

DMF 329712018

BIOPHORE INDIA PHARMACEUTICALS PVT LTDNIMODIPINE

DMF 342032019

LAKSH FINE CHEM PRIVATE LTDNIMODIPINE EP/BP/USP

DMF 436022026

BAYER HEALTHCARE AGInactiveNIMODIPINE

DMF 46641982

BAYER CORPInactiveNIMODIPINE CAPS 10MG (bay e 9736)

DMF 48161982

CATALENT PHARMA SOLUTIONS LLCInactiveNIMODIPINE 30MG SOFTGEL CAPSULES

DMF 155982001

USV LTDInactiveNIMODIPINE USP

DMF 178492004

CATALENT PHARMA SOLUTIONS LLCInactiveNIMODIPINE 30MG SOFTGELS

DMF 183732005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 30MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: May 2, 2007

No patent or exclusivity listings for this strength.